Disclosed are compounds of general formula (I),
wherein the groups A, R
1
, R
2
, R
a
and R
b
have the meanings given in the claims and specification, the tautomers, racemates, enantiomers, diastereomers and the mixtures thereof, and optionally the pharmacologically acceptable acid addition salts, solvates and hydrates thereof, and processes for preparing these thiazolyl-dihydro-quinazolines and the use thereof as pharmaceutical compositions.
Disclosed are N-[(1R,4S,6R)-3-(2-pyridinylcarbonyl)-3-azabicyclo[4.1.0]hept-4-yl]methyl}-2-heteroarylamine derivatives and their use as pharmaceuticals.
[EN] 3 -AZABICYCLO [4.1.0] HEPTANES USED AS OREXIN ANTAGONISTS<br/>[FR] 3 -AZABICYCLO [4.1.0] HEPTANES UTILISÉS COMME ANTAGONISTES DE L'OREXINE
申请人:GLAXO GROUP LTD
公开号:WO2010122151A1
公开(公告)日:2010-10-28
This invention relates to 3-azabicyclo[4.1.0] heptane derivatives (I) and their use as orexin receptor antagonists.
这项发明涉及3-氮杂双环[4.1.0]庚烷衍生物(I)及其作为促觉醒素受体拮抗剂的用途。
THIAZOLYL-DIHYDRO-INDAZOLE
申请人:Maier Udo
公开号:US20070259855A1
公开(公告)日:2007-11-08
Disclosed are compounds of general formula (I),
wherein the groups R
1
, R
2
, R
a
and R
b
have the meanings given in the claims and specification, the tautomers, racemates, enantiomers, diastereomers and the mixtures thereof, and optionally the pharmacologically acceptable acid addition salts, solvates and hydrates thereof, and processes for preparing these thiazolyl-dihydro-indazoles and the use thereof as pharmaceutical compositions.
A JNK inhibitor containing a compound having an isoquinolinone skeleton or a salt thereof, such as a compound represented by the formula
wherein ring A and ring B are each an optionally substituted benzene ring, X is -O-, -N=, -NR3- or -CHR3-, R2 is an acyl group, an optionally esterified or thioesterified carboxyl group, an optionally substituted carbamoyl group or an optionally substituted amino group and the like, a broken line shows a single bond or a double bond, and R1 is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group and the like, and the like.